EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Determination of OTNE-induced thyroid effects within an adverse outcome pathway (AOP) network

Etje Hulzebos, Todd Stedeford, Paul Sterchele, Gregory S Ladics

Food and Chemical Toxicology · 2024

DOI: 10.1016/j.fct.2024.114784 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Food and Chemical Toxicology, 2024. Verfasst von Etje Hulzebos und 3 weiteren Autor:innen. Beteiligte Einrichtung: International Flavors & Fragrances Inc., Liebergerweg 72-98, 1221 JT, Hilversum, the Netherlands. Hauptthemen laut MEDLINE: Adverse Outcome Pathways, Thyroid Gland. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Octahydro-tetramethyl-naphthalenyl-ethanone (OTNE) is a synthetic fragrance ingredient. OTNE was evaluated in repeated-dose toxicological studies. Target organs via oral and dermal routes were the liver and skin/liver, respectively. Effects were observed on the thyroid and thyroid hormones, suggesting hypothalamic-pituitary-thyroid axis perturbation. We investigated the molecular initiating event(s) (MIEs), key events (KEs), and adverse outcomes of OTNE-induced thyroid perturbation within an adverse outcome pathway (AOP). Data were generated using new approach methodologies (NAMs) on human, mouse, and/or rat receptors exploring MIEs using in vitro receptor ligand-binding assays for androstane receptor variant 3 (CAR), farnesoid X receptor (FXR), liver X receptor alpha (LXRα), peroxisome proliferator-activated receptors alpha, delta, and gamma (PPARα, δ, and γ), pregnane X receptor (PXR), and aryl hydrocarbon receptor (AhR). These data inform an AOP network where CAR, FXR, and PXR activation serve as MIEs with thyroid perturbation occurring as secondary effects. These data represent a robust evaluation using NAMs for mapping OTNE-induced thyroid effects and identifying activation of receptor-ligand binding as MIEs in lieu of additional in vivo experimentation. These data indicate the observed thyroid effects are secondary to liver effects and the thyroid effects, therefore, should not be the basis for assessing potential OTNE-induced human health hazards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Outcome PathwaysThyroid GlandAnimalsHumansMiceMaleRatsFemaleReceptors, Cytoplasmic and NuclearLiverThyroid Hormones

Stichwörter der Autor:innen

Adverse outcome pathwayNew approach methodologiesOTNEThyroid perturbation

Substanzen

Receptors, Cytoplasmic and NuclearThyroid Hormones

Autor:innen und Institutionen

  • International Flavors & Fragrances Inc., Liebergerweg 72-98, 1221 JT, Hilversum, the Netherlands.
  • Bergeson & Campbell, P.C., Washington, DC, 20037, USA.
  • IFF Inc., Hazlet, NJ, 07730, USA.
  • IFF Inc., Wilmington, DE, 19803, USA. Electronic address: gregory.s.ladics@iff.com.

Zitieren

APA

Hulzebos, E., Stedeford, T., Sterchele, P., & Ladics, G. S. (2024). Determination of OTNE-induced thyroid effects within an adverse outcome pathway (AOP) network. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2024.114784

Vancouver

Hulzebos E, Stedeford T, Sterchele P, Ladics GS. Determination of OTNE-induced thyroid effects within an adverse outcome pathway (AOP) network. Food and Chemical Toxicology. 2024. doi:10.1016/j.fct.2024.114784

BibTeX
@article{Hulzebos2024,
  author = {Hulzebos, Etje and Stedeford, Todd and Sterchele, Paul and Ladics, Gregory S},
  title = {Determination of OTNE-induced thyroid effects within an adverse outcome pathway (AOP) network},
  journal = {Food and Chemical Toxicology},
  year = {2024},
  doi = {10.1016/j.fct.2024.114784}
}
Kostenlos starten →